177 related articles for article (PubMed ID: 26655109)
1. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
Gaudette F; Sirhan-Daneau A; St-Onge M; Turgeon J; Michaud V
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():174-180. PubMed ID: 26655109
[TBL] [Abstract][Full Text] [Related]
2. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
[TBL] [Abstract][Full Text] [Related]
3. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
[TBL] [Abstract][Full Text] [Related]
4. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
Neuvonen M; Neuvonen PJ
Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
[TBL] [Abstract][Full Text] [Related]
5. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
Fang WB; Lofwall MR; Walsh SL; Moody DE
J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
[TBL] [Abstract][Full Text] [Related]
6. Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Edwards SR; Smith MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):264-70. PubMed ID: 17098487
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous LC-MS/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetric absorptive micro sampling.
Al-Qurain AA; Williams DB; Mackenzie L; Roberts MS; Wiese MD
J Pharm Biomed Anal; 2021 Sep; 203():114171. PubMed ID: 34087551
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of polar analytes using column-switching: application to oxycodone and three metabolites in human plasma.
Wagner M; Bourgogne E; Varesio E; Hopfgartner G
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):637-44. PubMed ID: 20138595
[TBL] [Abstract][Full Text] [Related]
9. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
[TBL] [Abstract][Full Text] [Related]
10. A sensitive LC-MS/MS method for the quantitation of oxycodone, noroxycodone, 6α-oxycodol, 6β-oxycodol, oxymorphone, and noroxymorphone in human blood.
Truver MT; Jakobsson G; Chermà MD; Swortwood MJ; Gréen H; Kronstrand R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122625. PubMed ID: 33744597
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatography.
Cheremina O; Bachmakov I; Neubert A; Brune K; Fromm MF; Hinz B
Biomed Chromatogr; 2005 Dec; 19(10):777-82. PubMed ID: 15920700
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
Chan S; Edwards SR; Wyse BD; Smith MT
Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Edwards SR; Smith MT
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):241-9. PubMed ID: 15639445
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of morphine, codeine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and 6-monoacetylmorphine (6-MAM) in urine, blood, serum, or plasma using liquid chromatography with tandem mass spectrometry detection.
Dahn T; Gunn J; Kriger S; Terrell AR
Methods Mol Biol; 2010; 603():411-22. PubMed ID: 20077093
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics of oxycodone and noroxycodone in male dark agouti and Sprague--Dawley rats: influence of streptozotocin-induced diabetes.
Huang L; Edwards SR; Smith MT
Pharm Res; 2005 Sep; 22(9):1489-98. PubMed ID: 16132361
[TBL] [Abstract][Full Text] [Related]
16. Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
Cone EJ; Zichterman A; Heltsley R; Black DL; Cawthon B; Robert T; Moser F; Caplan YH
Forensic Sci Int; 2010 May; 198(1-3):58-61. PubMed ID: 20036472
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method to quantify LY-354,740 in rat and marmoset plasma.
Gaudette F; Hamadjida A; Bédard D; Nuara SG; Beaudry F; Huot P
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():392-398. PubMed ID: 28802219
[TBL] [Abstract][Full Text] [Related]
18. Observations of urinary oxycodone and metabolite distributions in pain patients.
Elder NM; Atayee RS; Best BM; Ma JD
J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296
[TBL] [Abstract][Full Text] [Related]
19. A rapid and sensitive LC-MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone.
Hulskotte LMG; Wilbrink-Pijffers I; Arbouw MEL; Benoist GE; Jansman FGA; van Berlo-van de Laar IRF
Biomed Chromatogr; 2024 Apr; ():e5874. PubMed ID: 38587098
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
